1. Home
  2. SUPN vs SIMO Comparison

SUPN vs SIMO Comparison

Compare SUPN & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • SIMO
  • Stock Information
  • Founded
  • SUPN 2005
  • SIMO 1995
  • Country
  • SUPN United States
  • SIMO Hong Kong
  • Employees
  • SUPN N/A
  • SIMO N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • SIMO Semiconductors
  • Sector
  • SUPN Health Care
  • SIMO Technology
  • Exchange
  • SUPN Nasdaq
  • SIMO Nasdaq
  • Market Cap
  • SUPN 2.6B
  • SIMO 2.7B
  • IPO Year
  • SUPN 2012
  • SIMO 2005
  • Fundamental
  • Price
  • SUPN $44.80
  • SIMO $88.46
  • Analyst Decision
  • SUPN Buy
  • SIMO Strong Buy
  • Analyst Count
  • SUPN 2
  • SIMO 8
  • Target Price
  • SUPN $43.00
  • SIMO $84.38
  • AVG Volume (30 Days)
  • SUPN 654.2K
  • SIMO 264.3K
  • Earning Date
  • SUPN 11-03-2025
  • SIMO 10-29-2025
  • Dividend Yield
  • SUPN N/A
  • SIMO 2.26%
  • EPS Growth
  • SUPN 1411.53
  • SIMO N/A
  • EPS
  • SUPN 1.14
  • SIMO 2.30
  • Revenue
  • SUPN $665,125,000.00
  • SIMO $768,738,000.00
  • Revenue This Year
  • SUPN $4.84
  • SIMO $5.44
  • Revenue Next Year
  • SUPN $17.69
  • SIMO $15.56
  • P/E Ratio
  • SUPN $38.93
  • SIMO $39.25
  • Revenue Growth
  • SUPN 5.55
  • SIMO N/A
  • 52 Week Low
  • SUPN $29.16
  • SIMO $37.21
  • 52 Week High
  • SUPN $46.79
  • SIMO $91.20
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 58.16
  • SIMO 67.14
  • Support Level
  • SUPN $43.44
  • SIMO $77.22
  • Resistance Level
  • SUPN $46.72
  • SIMO $91.20
  • Average True Range (ATR)
  • SUPN 1.08
  • SIMO 3.01
  • MACD
  • SUPN -0.48
  • SIMO 0.72
  • Stochastic Oscillator
  • SUPN 40.60
  • SIMO 80.40

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: